Favier B - Search Results

1

Paclitaxel is effective in relapsed head and neck squamous cell carcinoma: a retrospective study of 66 patients at a single institution.

Fayette J, Montella A, Chabaud S, Bachelot T, Pommier P, Girodet D, Racadot S, Montbarbon X, Favier B, Zrounba P. Fayette J, et al. Among authors: favier b. Anticancer Drugs. 2010 Jun;21(5):553-8. doi: 10.1097/CAD.0b013e3283388e60. Anticancer Drugs. 2010. PMID: 20220515

2

Combination of rituximab with chemotherapy in diffuse large B-cell lymphoma. Evaluation in daily practice before and after approval of rituximab in this indication.

Ghesquières H, Ferlay C, Sebban C, Chassagne C, Carausu L, Gargi T, Favier B, Philip I, Blay JY, Biron P. Ghesquières H, et al. Among authors: favier b. Hematol Oncol. 2008 Sep;26(3):139-47. doi: 10.1002/hon.850. Hematol Oncol. 2008. PMID: 18383186

3

Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case series.

Labidi SI, Bachelot T, Ray-Coquard I, Mosbah K, Treilleux I, Fayette J, Favier B, Galy G, Blay JY, Guastalla JP. Labidi SI, et al. Among authors: favier b. Clin Breast Cancer. 2009 May;9(2):118-21. doi: 10.3816/CBC.2009.n.021. Clin Breast Cancer. 2009. PMID: 19433393

4

Efficacy of trabectedin for advanced sarcomas in clinical trials versus compassionate use programs: analysis of 92 patients treated in a single institution.

Fayette J, Boyle H, Chabaud S, Favier B, Engel C, Cassier P, Thiesse P, Méeus P, Sunyach MP, Vaz G, Ray-Coquard I, Ranchère D, Decouvelaere AV, Alberti L, Pérol D, Blay JY. Fayette J, et al. Among authors: favier b. Anticancer Drugs. 2010 Jan;21(1):113-9. doi: 10.1097/CAD.0b013e328333057b. Anticancer Drugs. 2010. PMID: 19887935 Clinical Trial.

5

Chemotherapy for metastatic breast cancer. Comparison of clinical practice and cost of drugs in two cohorts of patients: 1994-1998 and 2003-2006.

Galy G, Labidi-Galy SI, Perol D, Bachelot T, Ray-Coquard I, Tredan O, Biron P, Latour JF, Blay JY, Guastalla JP, Favier B. Galy G, et al. Among authors: favier b. Breast Cancer Res Treat. 2011 Jul;128(1):187-95. doi: 10.1007/s10549-010-1311-3. Epub 2010 Dec 24. Breast Cancer Res Treat. 2011. PMID: 21184270

6

First-line endocrine therapy alone could be a reasonable treatment option for hormone-positive, HER2-positive metastatic breast cancer.

Peron J, Tredan O, Ray-Coquard I, Bachelot T, Labidi Galy SI, Favier B, Treilleux I, Guastalla JP. Peron J, et al. Among authors: favier b. Bull Cancer. 2012 Feb 1;99(2):E18-25. doi: 10.1684/bdc.2011.1537. Bull Cancer. 2012. PMID: 22257781

7

Paclitaxel and cetuximab combination efficiency after the failure of a platinum-based chemotherapy in recurrent/metastatic head and neck squamous cell carcinoma.

Péron J, Ceruse P, Lavergne E, Buiret G, Pham BN, Chabaud S, Favier B, Girodet D, Zrounba P, Ramade A, Fayette J. Péron J, et al. Among authors: favier b. Anticancer Drugs. 2012 Oct;23(9):996-1001. doi: 10.1097/CAD.0b013e32835507e5. Anticancer Drugs. 2012. PMID: 22643048

8

Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients.

Heudel P, Favier B, Assaad S, Zrounba P, Blay JY. Heudel P, et al. Among authors: favier b. Ann Oncol. 2021 Nov;32(11):1443-1444. doi: 10.1016/j.annonc.2021.07.012. Epub 2021 Jul 30. Ann Oncol. 2021. PMID: 34333128 Free PMC article. No abstract available.

9

Rituximab in combination with adapted-dose of ifosfamide and etoposide as salvage treatment in elderly refractory/relapsed diffuse large B-cell lymphoma patients non-candidate for high dose therapy: a retrospective study.

Aussedat G, Maucort-Boulch D, Rey P, Safar V, Karlin L, Elsensohn MH, Bachy E, Lebras L, Favier B, Vantard N, Ghergus D, Golfier C, Sesques P, Lazareth A, Lequeu H, Ferrant E, Salles G, Nicolas-Virelizier E, Ghesquieres H. Aussedat G, et al. Among authors: favier b. Leuk Lymphoma. 2022 Mar;63(3):599-607. doi: 10.1080/10428194.2021.1998483. Epub 2021 Oct 31. Leuk Lymphoma. 2022. PMID: 34720034

10

Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients.

Heudel P, Favier B, Solodky ML, Assaad S, Chaumard N, Tredan O, Bachelot T, Ray-Coquard I, Russias B, Fournier ML, Mastroianni B, Avrillon V, Michallet AS, Zrounba P, Chabaud S, Perol D, Blay JY. Heudel P, et al. Among authors: favier b. Eur J Cancer. 2022 Apr;165:174-183. doi: 10.1016/j.ejca.2022.01.035. Epub 2022 Feb 10. Eur J Cancer. 2022. PMID: 35245864 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters